Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HS Biotech&Medical AB
AB
Active
Org 5569309114
Siktargatan 32, 753 17
Uppsala
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
HS Biotech&Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
166
0
524
Staff expenses
—
—
—
—
—
EBITDA
−14
−15
163
−4
505
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−14
−15
163
−4
505
Net financials
—
—
1
3
12
Profit before tax
−14
−15
163
−1
518
Tax
−0
−0
−28
−0
−107
Net profit
−14
−15
135
−1
411
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
866
555
457
388
957
Equity
842
527
388
387
798
Long-term debt
0
0
0
0
0
Short-term debt
24
28
69
1
159
Total debt
24
28
69
1
159
Financial ratios
5-year trend
EBITDA margin
96.4%
This company
15.8%
Market median
+510% vs market
2020
2024
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
2020
2024
Return on equity
51.5%
This company
18.4%
Market median
+180% vs market
2020
2024
Net profit margin
78.4%
This company
8.1%
Market median
+868% vs market
2020
2024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
2020
2024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on HS Biotech&Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
